Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Rivaroxaban shows promise in prevention of VTE in medically ill patients

April 19, 2011

BMS-650032 and BMS-790052 evaluated separately and combined in hepatitis C

April 19, 2011

Preclinical and clinical data presented on TRIN-2755 for solid tumors/sarcomas

April 18, 2011

Humanized MAb reverses dabigatran-induced anticoagulation in preclinical study

April 18, 2011

SDD-formulated bardoxolone methyl shows promise in patients with diabetes and chronic kidney disease

April 18, 2011

Niacin reduces phosphate levels in subjects with hyperphosphatemia due to hemodialysis

April 18, 2011

HM-781-36B displays potent inhibitory effects in erbB-1-dependent tumors

April 18, 2011

Treatment of hepatitis C with IDX-184 is not linked to resistance mutations

April 18, 2011

In vitro profile supports first-in-human study of GSK-2336805 for hepatitis C

April 18, 2011

Promising data disclosed from PEPPER trial of Pantera Lux paclitaxel-releasing balloon

April 18, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...